antigen
demonstr
rhabdovirus
retrovirus
griffin
compan
bubber
lilli
place
host
protein
viral
code
protein
becom
substitut
envelop
envelop
virus
except
togavirus
envelop
overli
matrix
protein
play
import
role
assembl
releas
virion
addit
strutur
protein
virus
carri
enzym
necessari
replic
although
virus
possess
capsid
helic
cubic
symmetri
complex
structur
retrovirus
helic
nucleocapsid
surround
outer
icosahedr
capsid
whilst
pox
virus
even
elabor
substructur
membran
enzym
viru
infect
present
immun
system
rang
protein
antigen
biolog
import
viral
antigen
howev
larg
depend
locat
function
antigen
viral
replic
neutralis
antibodi
antibodi
render
viru
noninfecti
direct
toward
antigen
surfac
virion
case
envelop
virus
glycoprotein
spike
viru
except
occur
howev
bovin
leukaemia
viru
infect
instanc
antibodi
produc
glycosol
determin
wherea
immunis
inactiv
viru
result
antibodi
protein
compon
portel
et
al
cytotox
tcell
also
recognis
carbohydr
ertl
ada
suggest
gene
major
histocompat
complex
code
glycosyl
transferas
attach
specif
oligosaccharid
viral
protein
render
antigen
blanden
et
al
glycoprotein
viral
envelop
also
express
cell
surfac
addit
antigen
normal
access
surfac
virion
found
cell
membran
matrix
protein
influenza
viru
report
express
low
level
cell
surfac
hackett
et
al
felin
leukaemia
viru
infect
novel
antigen
consist
glycosal
intern
antigen
precursor
protein
express
plasma
membran
neil
et
al
surfac
protein
nonenvelop
virus
glycosal
envelop
virus
target
neutralis
antibodi
addit
surfac
protein
envelop
nonenvelop
virus
may
bind
erythrocyt
haemagglutin
antibodi
specif
haemagglutinin
virus
inhibit
haemagglutin
activ
reaction
provid
conveni
method
measur
antiviru
antibodi
mainten
repeat
epitop
regular
fashion
surfac
virus
might
expect
indic
structur
would
function
thymu
independ
antigen
experiment
investig
humor
respons
athym
nude
mice
nunu
viru
infect
suggest
howev
respons
antigen
either
complet
thymu
depend
requir
thymic
function
switch
igm
igg
respons
burn
antibodi
produc
intern
antigen
virus
expos
intact
virion
therefor
contain
target
natur
immun
respons
virus
govern
part
relationship
viru
host
cell
examin
relationship
conveni
consid
nonenvelop
virus
envelop
virus
separ
virus
oblig
intracellular
parasit
depend
host
cell
machineri
replic
properti
member
certain
viru
group
particularli
herpesviru
retroviru
paramyxoviru
group
abil
remain
latent
infect
state
viru
repres
host
cell
genom
without
product
complet
virion
herp
viru
infect
latent
state
usual
maintain
neuron
lymphoid
tissu
whilst
felin
leukaemia
viru
infect
retroviru
latenc
maintain
bone
marrow
rojko
et
al
reactiv
latent
state
product
new
viru
particl
occur
herp
viru
infect
may
also
associ
recrudesc
clinic
sympton
amongst
agent
associ
reactiv
latenc
rang
immunosuppress
product
case
felin
leukaemia
viru
felv
latent
state
appear
associ
activ
cellular
humor
immun
respons
direct
express
viral
antigen
cell
surfac
rojko
et
al
powel
et
al
witter
et
al
choic
test
use
measur
antibodi
respons
virus
often
base
pragmat
criteria
complement
fixat
enzym
link
immunosorb
assay
provid
easili
autom
screen
test
examin
larg
number
sampl
epidemiolog
survey
whole
viru
use
antigen
test
howev
subgroup
specif
often
obscur
group
specif
reaction
virus
haemagglutin
haemagglutin
inhibit
test
provid
quantit
assay
inexpens
quick
perform
furthermor
often
subgroup
specif
rang
avail
serolog
test
viru
neutralis
occupi
special
posit
sinc
definit
detect
antibodi
result
loss
viru
infect
viru
neutralis
assay
therefor
provid
mean
assess
protect
humor
respons
vitro
assay
conduct
two
stage
viru
known
titr
first
incub
heat
inactiv
serum
test
interv
minut
hour
residu
infect
measur
indic
system
sensit
assay
larg
govern
sensit
indic
system
usual
permiss
cell
cultur
neutralis
assay
conduct
constant
amount
viru
variabl
titr
serum
concentr
assay
antibodi
usual
excess
condit
percentag
surviv
viru
neutralis
independ
initi
quantiti
viru
employ
order
replic
viru
particl
must
bind
target
cell
enter
final
uncoat
liber
nucleic
acid
genom
neutralis
antibodi
shown
interfer
function
surviv
fraction
viru
examin
differ
time
nuetralis
reaction
curv
illustr
figur
gener
curv
immedi
decreas
surviv
fraction
observ
proport
viru
neutralis
given
time
interv
pattern
one
hit
kinet
taken
indic
singl
antibodi
molecul
requir
neutralis
viru
particl
howev
neutralis
reaction
conduct
low
antibodi
concentr
low
temperatur
chang
curv
occur
lag
onset
rapid
neutralis
lag
phase
consist
model
propos
meynel
meynel
howev
mechan
neutralis
may
complex
evid
suggest
neutralis
influenza
viru
adsorb
uncoat
suitabl
host
cell
transcript
viral
genom
occur
dimmock
posse
suggest
virusantibodi
complex
may
activ
cellular
nucleas
may
account
neutralis
viru
enter
cell
mandel
adenovirus
definit
critic
site
complex
capsid
consist
hexon
capsomer
penton
base
capsomer
arrang
vertic
icosahedron
project
penton
base
fibr
complex
fibr
penton
base
term
penton
fig
hexon
possess
distinct
site
group
specif
type
specif
determin
wherea
type
specif
determin
predomin
fibr
norrbi
pettersson
neutralis
antibodi
direct
larg
hexon
whilst
antipenton
serum
weak
neutralis
activ
antifibr
serum
hardli
kjellen
pereira
although
antipenton
serum
low
neutralis
activ
consider
enhanc
neutralis
effect
antihexon
antibodi
hierholz
dowdl
furthermor
antipenton
serum
alon
signific
neutralis
capac
addit
antiglobulin
norrbi
wadel
suggest
critic
site
confin
hexon
alon
maxim
neutralis
reaction
involv
antibodi
reaction
one
site
possibl
except
multipl
site
neutralis
occur
picornavirida
polioviru
found
combin
singl
antibodi
molecul
associ
chang
isoelectr
point
viru
taken
indic
distort
capsid
structur
preced
neutralis
mandel
fig
rapid
phase
neutralis
obey
first
order
kinet
follow
slower
phase
level
viru
neutralis
pronounc
leav
persist
fraction
fig
persist
fraction
frequent
observ
low
avid
antibodi
occur
earli
infect
immunis
antibodi
disassoci
virusantibodi
complex
dilut
lead
reactiv
viru
lafferti
suggest
persist
fraction
also
aris
viru
form
aggreg
virion
unavail
neutralis
antibodi
howev
persist
fraction
observ
monodispers
viru
high
avid
antibodi
use
neutralis
reaction
condit
addit
immunoglobulin
persist
fraction
result
addit
neutralis
fab
fragment
employ
neutralis
occur
ash
et
al
reason
interpret
smaller
fab
fragment
abl
reach
site
virion
inaccess
larger
intact
immunoglobulin
stearic
inhibit
neutralis
antibodi
could
occur
bind
antibodi
noncrit
site
leav
critic
site
avail
interact
host
cell
fig
increas
bodi
evid
indic
import
complement
antivir
respons
complement
play
role
neutralis
free
viru
elimin
viru
infect
cell
activ
initi
follow
way
immun
activ
complement
pathway
lead
viru
neutralis
ii
iii
nonimmun
activ
altern
classic
pathway
complement
virion
viru
infect
cell
envelop
virus
theori
suscept
damag
activ
termin
phospholipas
complement
pathway
addit
purifi
compon
complement
system
sequenc
shown
enhanc
neutralis
equin
arter
virusantibodi
complex
radwan
crawford
similarli
addit
complement
retrovirusantibodi
complex
associ
loss
structur
integr
viral
envelop
consequ
loss
infect
oroszlan
gilden
avian
infecti
bronchiti
viru
coronaviru
berri
almeida
demonstr
punctat
lesion
envelop
associ
lytic
complement
damag
howev
also
found
neutralis
could
occur
without
lesion
evid
indic
virolysi
absolut
requir
ablat
infect
indic
virolysi
necessarili
prerequisit
neutralis
envelop
virus
confirm
addit
earli
compon
complement
pathway
herp
virusantibodi
complex
daniel
et
al
sequenti
addit
ci
signific
neutralis
first
detect
upon
addit
increas
ad
neutralis
earli
compon
probabl
occur
mask
cell
receptor
virion
surfac
although
aggreg
viral
particl
suggest
possibl
mechan
oldston
et
al
bind
virion
may
also
play
import
role
remov
immun
complex
phagocyt
cell
system
whilst
anaphylatoxin
gener
cleavag
promot
inflammatori
respons
appear
import
limit
cell
cell
spread
herpesvirus
paramyxovirus
strike
featur
altern
pathway
complement
activ
absenc
immunoglobulin
may
reflect
posit
evolutionari
origin
altern
pathway
amplif
system
inflammatori
reaction
later
gene
duplic
form
classic
termin
pathway
lachman
hobart
essenti
featu
altern
pathway
illustr
figur
pathway
posit
feedback
cycl
result
cleavag
mllereberhard
gstze
suggest
altern
pathway
constantli
tick
result
random
deposit
complement
lachmann
nicol
whether
continu
deposit
occur
paticular
surfac
depend
extent
bound
avail
factor
h
pangburn
et
al
hypothesi
illustr
figur
bind
site
activ
surfac
mask
inactiv
factor
h
bind
site
allow
format
activ
altern
pathway
absenc
immunoglobuin
viru
infect
sisson
et
al
viru
transform
cell
budzko
et
al
mcconnel
et
al
report
recent
although
activ
complement
occur
without
antibodi
lysi
rang
human
cell
infect
envelop
virus
requir
intact
altern
pathway
antivir
igg
even
absenc
lysi
coat
cell
could
becom
suscept
damag
phagocyt
cell
fig
nonimmun
activ
complement
pathway
also
produc
viru
particl
retrovirus
lyse
fresh
human
serum
serum
number
speci
welsh
et
al
activ
cl
virion
surfac
appear
e
analag
fusion
protein
virus
bartholomew
et
al
welsh
et
al
cooper
et
al
suggest
capac
serum
lyse
retrovirus
without
antibodi
may
relat
absenc
retroviru
viraemia
speci
regard
interest
plasma
viraemia
retrovirus
occur
cat
serum
speci
lyse
retrovirus
n
gorman
pet
comm
envelop
virus
also
associ
activ
complement
pathway
although
activ
often
depend
cell
viru
passag
welsh
activ
altern
pathway
record
newcastl
diseas
viru
welsh
moloney
leukaemia
viru
bartholomew
et
al
although
latter
case
activ
weak
probabl
biolog
signific
curiou
featur
role
antibodi
envelop
viru
infect
presenc
requir
lysi
cell
yet
respons
activ
complement
pathway
presenc
earli
compon
classic
pathway
appear
requir
perrin
et
al
lysi
measl
infect
hela
cell
produc
purifi
compon
altern
membran
attack
pathway
sisson
et
al
properidin
also
necessari
lysi
whilst
neither
igg
properidin
influenc
absolut
bind
target
rate
bind
increas
igg
stabil
complex
increas
properidin
combin
process
may
facilit
format
convertas
subsequ
assembl
membran
attack
complex
sisson
et
al
paramyxovirus
possess
two
envelop
glycoprotein
hn
h
antif
antibodi
circumst
viru
still
abl
spread
cell
cell
fusion
adjac
plasma
membran
sinc
antif
antibodi
necessari
inhibit
activ
fig
merz
et
al
furthermor
absenc
antif
antibodi
continu
hn
antigen
present
occur
form
viru
releas
expand
syncitia
antigenantibodycompl
complex
form
process
may
account
immunopatholog
respons
observ
respiratori
synciti
rs
measl
viru
infect
chatterji
mankad
kim
et
al
interestingli
severest
pneumonia
rs
viru
infect
occur
children
highest
neutralis
antibodi
titr
chanock
et
al
rsv
induc
diseas
cattl
suggest
immunopatholog
compon
kim
inher
problem
evalu
signific
vitro
phenomena
term
biolog
relev
vivo
doubt
cast
import
complement
mediat
lysi
sinc
rel
larg
amount
antibodi
requir
effect
lysi
case
measl
infect
cell
x
molecul
igg
per
cell
requir
lysi
sisson
et
al
protect
tumour
develop
immunopatholog
featur
mani
viru
diseas
infecti
periton
pedersen
boyl
weiss
scott
diseas
viru
infect
persist
despit
vigor
humor
respons
continu
product
viru
antigen
face
antibodi
respons
result
format
immun
complex
eventu
format
complex
overwhelm
abil
phagocyt
system
degrad
becom
deposit
glomeruli
arteri
virus
quit
differ
group
involv
immun
complex
diseas
interest
parallel
biolog
antibodi
produc
viru
may
nonneutralis
aleutian
diseas
whilst
neutralis
antibodi
produc
eia
infect
clear
viru
circul
nonneutralis
viru
antibodi
complex
mcguir
et
al
eia
diseas
episod
new
episod
appear
associ
antigen
variant
neutralis
antibodi
effect
virus
present
earlier
cours
diseas
kono
et
al
second
featur
common
virus
replic
macrophag
although
necessarili
major
site
viru
kohl
et
al
shore
et
al
polymorphonuclear
leucocyt
gale
zighelboim
tcell
santoli
koprowski
speci
main
bodi
evid
suggest
effici
effector
kcell
activ
peripher
blood
fc
bear
cell
null
set
mononuclear
cell
nonadher
erossett
neg
surfac
igcel
greenberg
et
al
howev
differ
effector
cell
may
act
differ
situat
may
speci
differ
effect
cell
popul
initi
adcc
dog
adcc
activ
distemp
infect
cell
produc
null
cell
popul
compar
kcell
man
ho
babiuk
whilst
cattl
adcc
herp
viru
infect
cell
mediat
effici
neutrophil
grewal
et
al
latter
case
howev
found
neutrophil
could
also
exert
antivir
effect
distinct
adcc
requir
direct
interact
neutrophil
target
cell
featur
adcc
suggest
may
relev
vivo
rel
littl
antibodi
requir
sensitis
cell
comparison
complement
depend
cytotox
hela
cell
use
target
estim
x
antibodi
molecul
per
cell
requir
sensitis
figur
least
one
order
magnitud
lower
complement
mediat
cytotox
perrin
et
al
high
concentr
antibodi
may
even
inhibit
adcc
possibl
antigen
modul
target
cell
result
complex
block
fc
receptor
effector
cell
andersson
et
al
mechan
lysi
produc
kcell
understood
system
antibodi
must
first
bind
target
cell
greenberg
step
occur
effector
cell
interact
fc
portion
immunoglobulin
molecul
effect
lytic
process
vitro
lytic
process
develop
rapidli
membran
damag
detect
within
minut
plate
effector
cell
ziegler
henney
lytic
phase
kinet
cell
kill
measur
releas
demonstr
one
hit
pattern
indic
singl
effector
target
cell
inter
necessari
produc
lysi
contradistinct
tcell
kill
effector
cell
bound
target
inactiv
unabl
participt
cytolyt
action
ziegler
henney
signfic
adcc
vivo
still
clear
cytotox
viru
infect
cell
measur
vitro
two
princip
way
microcytox
assay
adher
target
cell
plate
microwel
abil
lymphocyt
kill
target
day
measur
direct
count
remain
viabl
cell
end
assay
takasugi
klein
whilst
sensit
assay
timeconsum
subject
consider
variabl
furthermor
necessarili
distinguish
cytotox
growth
inhibit
wide
use
test
releas
assay
cerrotini
brunner
doherti
et
al
takasugi
et
al
kiessl
et
al
intuit
attract
hypothesi
nk
function
cell
repres
class
null
cell
respons
adcc
nk
activ
due
prearm
fc
receptor
antibodi
studi
human
murin
nk
cell
similar
k
cell
report
kay
et
al
santoni
although
nk
activ
may
found
nonadher
mononuclear
popul
peripher
blood
man
spleen
mice
lymphoid
compart
cat
mccarti
pig
huh
et
al
chicken
lam
linna
speci
certain
cell
ident
kcell
render
natur
cell
mediat
cytox
ncmc
suscept
block
antilgg
f
ab
fragment
antiimmunoglobulin
whilst
antiimmunoglobulin
effect
block
adcc
trinchieri
et
al
fail
inhibit
partial
inhibit
ncmc
kay
et
al
pape
et
al
distinguish
ncmc
adcc
activ
nevertheless
requir
use
care
control
sinc
nk
activ
often
measur
long
assay
antibodi
may
secret
vitro
pbl
instanc
appar
increas
spontan
cytox
pbl
influenza
viru
vaccin
shown
correl
abil
produc
antihaemagglutinin
antibodi
vitro
greenberg
et
al
solut
dichotomi
similar
popul
produc
nk
adcc
activ
differ
suscept
respons
antiimmunoglobulin
suggest
santoli
koprowski
propos
adcc
ncmc
differ
cytolyt
process
mediat
popul
suggest
support
data
ojo
wigzel
inform
natur
human
nk
cell
suggest
nonadher
surfac
ig
neg
cell
fc
receptor
low
avid
use
human
nk
cell
elut
target
saksela
et
al
found
roset
sheep
red
blood
cell
srbc
display
acid
anapthyl
acet
esteras
stain
pattern
typic
lymphocyt
santoli
koprowski
also
found
proport
nk
activ
amongst
srbc
roset
igg
fc
popul
suggest
human
nk
cell
may
belong
tglymphocyt
subset
display
suppressor
cell
activ
moretta
et
al
murin
nk
cell
exhibit
product
also
found
surfac
thymocyt
bcell
macrophag
cantor
et
al
furthermor
either
low
express
thyi
antigen
heberman
et
al
find
would
consist
murin
nk
cell
belong
earli
stage
tcell
lineag
herberman
holden
recent
studi
howev
suggest
posit
cell
may
relat
basophil
galli
et
al
mous
signific
strain
differ
nk
activ
observ
level
activ
appear
link
gene
major
histocompat
complex
apart
strain
differ
profound
select
defect
nk
activ
record
homozyg
beig
mice
roder
duw
target
cell
specif
nk
activ
nk
cell
appear
exhibit
cytolyt
activ
wide
rang
cell
activ
appear
highest
allogen
cell
hannson
et
al
cell
cultur
vitro
particularli
lymphoid
cell
kiessl
et
al
differ
suscept
ncmc
differ
cell
line
appear
relat
acquisit
antigen
cultur
media
haller
import
question
therefor
specif
recognit
event
nk
cell
use
techniqu
nk
cell
deplet
bind
differ
target
cell
kiessl
wigzel
found
deplet
nk
activ
specif
particular
target
correl
suscept
target
ncmc
similar
find
record
nk
activ
viru
infect
cell
whilst
viru
infect
cell
suscept
nk
activ
noninfect
counterpart
cold
competit
target
absorpt
studi
suggest
lysi
effect
popul
capabl
cytotox
rang
target
cell
weston
et
al
addit
antivir
activ
interferon
rang
immunosuppress
effect
epstein
includ
former
enhanc
effect
interferon
nk
cell
activ
addit
respond
exogen
interferon
nk
compon
lymphocyt
use
cytotox
assay
activ
interferon
produc
endogen
assay
infect
target
cell
consequ
caution
requir
interpret
result
adcc
tcell
mediat
cytotox
assay
viru
infect
cell
possibl
regulatori
role
interferon
ncmc
suggest
observ
interferon
activ
nk
cell
also
induc
protect
effect
ncmc
normal
uninfect
fibroblast
thymu
ablat
suscept
envelop
virus
increas
whilst
immun
respons
nonenvelop
virus
remain
near
normal
blanden
zisman
ragerzisman
induct
cell
mediat
respons
viral
antigen
associ
number
event
monitor
includ
delay
hypersensit
respons
prolifer
tcell
releas
lymphokin
includ
gamma
interferon
howev
central
event
tcell
mediat
immun
destrut
viru
infect
cell
cytotox
tcell
major
develop
studi
tcell
mediat
immun
observ
cytotox
activ
murin
tcell
restrict
viru
infect
target
cell
bear
major
histocompat
mhc
antigen
mhc
restrict
could
demonstr
cytotox
effector
function
requir
recognit
gene
product
k
region
mhc
tcell
helper
activ
restrict
region
product
zinkernagel
doherti
doherti
zinkernagel
znkernagel
doherti
restrict
primarili
mhc
product
present
irradi
resist
thymic
epithelium
zinkernagel
et
al
secondli
pioneer
transplant
surgeri
soon
discov
mhc
product
strong
antigen
estim
tcell
may
specif
react
foreign
haplotyp
dutton
swain
et
al
high
degre
mhc
polymorph
associ
alloreact
presum
import
role
govern
respons
antigen
thirdli
becom
clear
tcell
specif
particular
antigen
bear
idiotyp
ident
antibodi
specif
antigen
binz
wigzel
least
part
tcell
antigen
receptor
repetoir
therefor
probabl
encod
vh
gene
howev
unlik
vh
gene
express
bcell
believ
product
somat
mutat
ontogeni
vh
gene
tcell
may
limit
encod
germ
line
may
account
failur
observ
increas
affin
tcell
receptor
antigen
develop
immun
respons
krawinkel
et
al
within
constraint
given
number
model
antigen
recognit
tcell
possibl
extrem
exampl
alter
self
dual
recognit
model
fig
earli
discuss
tcell
receptor
centr
alter
self
model
assum
antigen
associ
mhc
product
creat
conform
chang
latter
alter
mhc
product
could
recognis
singl
tcell
receptor
dual
recognit
model
envis
separ
receptor
exist
mhc
product
antigen
intermedi
form
model
associ
recognit
model
involv
singl
receptor
recognis
unmodifi
mhc
product
togeth
antigen
fig
recent
dual
receptor
model
predomin
cohn
epstein
zinkernagel
et
al
williamson
issu
still
far
resolv
recent
resurg
alter
self
hypothesi
matzing
whichev
model
correct
appar
recognit
antigen
associ
mhc
govern
extent
immun
respons
polymorph
mhc
product
speci
may
maintain
select
pressur
varieti
infecti
diseas
popul
evok
distinct
level
respons
given
mhc
product
mhcrestrict
tcell
cytotox
observ
speci
includ
man
speci
veterinari
interest
indic
mhc
restrict
observ
chicken
immun
roussarcoma
viru
infect
cell
wainberg
et
al
appar
absenc
mhc
restrict
cytotox
reaction
cattl
ibr
vaccinia
viru
infect
term
cultur
onion
et
al
rojko
et
al
addit
progress
made
defin
mhc
product
number
domest
anim
includ
dog
vriesendorp
develop
regul
cytotox
respons
requir
interact
distinct
tcell
subset
involv
tcell
help
suppress
induct
immun
respons
also
depend
macrophag
zisman
et
al
function
antigen
present
cell
latter
function
carri
la
group
cell
may
distinct
lamacrophag
involv
remov
antibodycomplementviru
complex
finberg
benacerraff
tlymphocyt
subset
involv
murin
immun
respons
earli
stage
induct
immun
respons
involv
lyt
cell
interact
viru
antigen
present
surfac
la
macrophag
helper
cell
requir
two
signal
activ
one
specif
signal
provid
recognit
antigen
region
product
whilst
second
probabl
nonspecif
lymphokin
interleukin
ill
releas
antigen
present
cell
activ
helper
cell
produc
interleukin
factor
may
role
enhanc
differenti
lyt
precursor
princip
function
act
second
signal
induct
cytotox
respons
analag
fashion
gener
tcell
help
cytotox
tcell
must
recognis
viral
antigen
mhc
product
case
recognis
k
mhc
structur
cytotox
lymphocyt
interact
antigen
express
receptor
becom
sensit
releas
helper
cell
interleukin
appear
necessari
activ
cytotox
tcell
former
name
tcell
growth
factor
suggest
import
expand
cytotox
pool
zinkernagel
rosenth
light
observ
surpris
find
cytotox
tcell
often
show
cross
reactiv
serolog
defin
viru
subgroup
instanc
may
type
specif
reaction
cytotox
assay
obscur
group
specif
cytotox
event
appar
exampl
phenomenon
cross
reactiv
murin
cytotox
tcell
target
cell
infect
differ
strain
influenza
virus
origin
thought
due
recognit
tcell
membranebound
groupspecif
matrix
protein
howev
quantit
amount
matrix
protein
cell
membran
make
unlik
explan
hackettt
et
al
indic
tcell
may
express
broad
specif
antigen
variabl
haemagglutinin
molecul
influenza
viru
one
signific
achiev
medicin
last
centuri
control
major
viru
diseas
vaccin
sinc
work
jenner
pasteur
progress
often
achiev
inspir
emperic
littl
refer
theoret
immunolog
nevertheless
alway
remain
core
import
diseas
amen
vaccin
control
diseas
undoubtedli
requir
new
insight
protect
immun
respons
essex
klein
g
snyder
p
et
al
correl
humor
antibodi
regress
tumour
induc
felin
sarcoma
viru
natur
finberg
r
benacerraff
b
induct
control
consequ
viru
specif
cytotox
cell
immunolog
rev
fujinami
r
oldston
mba
antivir
antibodi
react
plasma
membran
alter
measl
viru
express
insid
cell
natur
